Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Current Oncology Reports|November 4, 2021
Is Myelodysplasia a Consequence of Normal Aging?Sonja Heibl, Reinhard Stauder, Michael Pfeilstöcker
Leukemia Research|January 3, 2006
Expression and functional significance of osteocalcin splicing in disease progression of hematological malignanciesPeter Wihlidal, Franz Varga, Michael Pfeilstöcker, et al.
Leukemia Research|October 5, 2011
Time changes in predictive power of established and recently proposed clinical, cytogenetical and comorbidity scores for Myelodysplastic SyndromesMichael Pfeilstöcker, Heinz Tüchler, Anabel Schönmetzler, et al.
Leukemia Research|September 8, 2007
Imatinib mesylate (IM)-induced growth inhibition is associated with production of spliced osteocalcin-mRNA in cell linesPeter Wihlidal, Heidrun Karlic, Michael Pfeilstöcker, et al.
Comparative Immunology, Microbiology and Infectious Diseases|February 12, 2008
Preanalytic removal of human DNA eliminates false signals in general 16S rDNA PCR monitoring of bacterial pathogens in bloodMichael Handschur, Heidrun Karlic, Christian Hertel, et al.
Annals of Hematology|November 28, 2002
Assessment of growth and differentiation processes in myelodysplastic syndromes by PCR analysis of Galpha16 and 5'-lipoxygenaseMichael Pfeilstöcker, Heidrun Karlic, Thomas Nösslinger, et al.
Annals of Hematology|November 13, 2024
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy- a report of two casesJulia Riedl, Michael Pfeilstöcker, Alex Farr, et al.
Leukemia & Lymphoma|October 22, 2013
Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemiaAngelika Valentin, Katharina Troppan, Michael Pfeilstöcker, et al.
Leukemia & Lymphoma|October 6, 2007
Myelodysplastic syndromes, aging, and age: correlations, common mechanisms, and clinical implicationsMichael Pfeilstöcker, Heidrun Karlic, Thomas Nösslinger, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 18, 2008
Impact of age and comorbidity in myelodysplastic syndromesReinhard Stauder, Thomas Nösslinger, Michael Pfeilstöcker, et al.
Pageof 6